Studies examine optimal topical, systemic Txs for AD
Two reviews from researchers at McMaster University in Hamilton have identified the most effective topical and systemic treatments for...
top of page
it's where dermatology lives
John Evans
Sep 1, 20232 min read
Dupilumab improves blood vessel barrier function in AD
In a recent study, researchers at National Jewish Health investigated the impact of dupilumab on the vascular barrier function in...
Allan Ryan
Sep 26, 20222 min read
Dupilumab effective in relieving AD symptoms in children aged six months to six years
Children with eczema between the ages of six months and six years benefit from treatment with dupilumab, according to the results of a...
Featured Posts
bottom of page